Ameriprise’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152M | Sell |
|
|||||
|
2025
Q1 | $216M | Buy |
|
|||||
|
2024
Q4 | $232M | Sell |
|
|||||
|
2024
Q3 | $386M | Sell |
|
|||||
|
2024
Q2 | $395M | Buy |
|
|||||
|
2024
Q1 | $320M | Sell |
|
|||||
|
2023
Q4 | $295M | Sell |
|
|||||
|
2023
Q3 | $301M | Sell |
|
|||||
|
2023
Q2 | $271M | Buy |
|
|||||
|
2023
Q1 | $294M | Buy |
|
|||||
|
2022
Q4 | $242M | Buy |
|
|||||
|
2022
Q3 | $204M | Sell |
|
|||||
|
2022
Q2 | $182M | Sell |
|
|||||
|
2022
Q1 | $278M | Sell |
|
|||||
|
2021
Q4 | $257M | Buy |
|
|||||
|
2021
Q3 | $230M | Sell |
|
|||||
|
2021
Q2 | $230M | Buy |
|
|||||
|
2021
Q1 | $135M | Buy |
|
|||||
|
2020
Q4 | $132M | Sell |
|
|||||
|
2020
Q3 | $155M | Buy |
|
|||||
|
2020
Q2 | $170M | Sell |
|
|||||
|
2020
Q1 | $141M | Sell |
|
|||||
|
2019
Q4 | $119M | Buy |
|
|||||
|
2019
Q3 | $87.6M | Buy |
|
|||||
|
2019
Q2 | $90.4M | Buy |
|
|||||
|
2019
Q1 | $117M | Sell |
|
|||||
|
2018
Q4 | $111M | Buy |
|
|||||
|
2018
Q3 | $120M | Sell |
|
|||||
|
2018
Q2 | $109M | Buy |
|
|||||
|
2018
Q1 | $96M | Buy |
|
|||||
|
2017
Q4 | $93.2M | Buy |
|
|||||
|
2017
Q3 | $97.9M | Buy |
|
|||||
|
2017
Q2 | $107M | Sell |
|
|||||
|
2017
Q1 | $108M | Sell |
|
|||||
|
2016
Q4 | $130M | Buy |
|
|||||
|
2016
Q3 | $110M | Buy |
|
|||||
|
2016
Q2 | $26.7M | Buy |
|
|||||
|
2016
Q1 | $12.6M | Sell |
|
|||||
|
2015
Q4 | $50.6M | Sell |
|
|||||
|
2015
Q3 | $82.4M | Buy |
|
|||||
|
2015
Q2 | $42.1M | Buy |
|
|||||
|
2015
Q1 | $36.6M | Buy |
|
|||||
|
2014
Q4 | $13.9M | Buy |
|
|||||
|
2014
Q3 | $11.6M | Sell |
|
|||||
|
2014
Q2 | $9.47M | Buy |
|
|||||
|
2014
Q1 | $9.89M | Sell |
|
|||||
|
2013
Q4 | $19.9M | Sell |
|
|||||
|
2013
Q3 | $57.5M | Buy |
|
|||||
|
2013
Q2 | $31M | Buy |
|